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Abstract
Every year millions of people worldwide are affected by Ulcerative Colitis (UC) and
Crohn’s Disease (CD), two chronic diseases that are marked by acute phases. The Enduring
Somatic Threat (EST) model was proposed to address the trauma that results from ongoing
somatic concerns rather than discrete external events. Prior research has shown that people living
with acute conditions experience symptoms of Post-Traumatic Stress Disorder (PTSD); however,
very little research has been conducted concerning the relationship between UC and CD and
symptoms of PTSD and whether the EST model could be extended to the UC/CD population.
Additionally, literature suggests that remission status and posttraumatic growth could buffer the
negative effects of living with UC or CD and may serve as moderators in the relationship
between symptoms of UC/CD and PTSD symptoms. This study aimed to expand the EST model
into the IBD population by exploring whether patients with UC and CD endorsed clinically
significant levels of PTSD symptomology, what constellations of PTSD symptoms were related
to IBD, and whether posttraumatic growth and remission-related variables moderated the
relationship between both UC/CD concerns and symptoms of PTSD. Results This study found
that 32.8% of participants met the cutoff for PTSD symptom endorsement that would warrant
further diagnostic inquiry. Further, re-experiencing, reactivity and negative alterations in mood
were more strongly associated with IBD-related worries and concerns and all the trauma
symptom clusters and body vigilance were significantly correlated with UC/CD impact.
Finally, it was found that posttraumatic growth did not moderate UC/CD concerns, but aspects of
remission did moderate the relationships between aspects of UC/CD concerns and trauma
symptoms.
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Introduction
Inflammatory bowel disease (IBD) is a broad term that describes chronic, relapsing, and
remitting gastrointestinal diseases (Ananthakrishnan, 2015; Bousvaros et al., 2007; Conrad,
Roggenbuck, & Laass, 2014; Laass, Roggenbuck, & Conrad, 2014). The two autoimmune
diseases that are primarily discussed under this term are ulcerative colitis (UC) and Crohn’s
Disease (CD). The broader term of IBD is often used to describe both UC and CD, and IBD and
UC/CD will be used interchangeably throughout this paper. UC and CD are both prevalent
worldwide. In the United States, it is estimated that 1.5 million people are affected by IBD; in
Europe, 2.2 million are affected (Ananthakrishnan, 2015). The symptoms of IBD include, but are
not limited to, diarrhea, rectal bleeding, abdominal cramping and pain, urgency to move bowels,
constipation, fever, weight loss, night sweats, and fatigue (Bousvaros et al., 2007; Conrad et al.,
2014; Laass et al., 2014). Additionally, both UC and CD are autoimmune diseases, which are
marked by an abnormal response by the body in which the immune system attacks healthy cells
in the gastrointestinal tract (Cleynen et al., 2016).
There is no cure for IBD, and medical treatment is aimed at addressing the inflammation
and symptoms during a flare and preventing flare-ups through adherence to treatment (Conrad et
al., 2014; Laass et al., 2014; Peyrin-Biroulet et al., 2016; Sajadinejad, Asgari, Molavi, Kalantari,
& Adibi, 2012). These treatments can include surgical interventions, steroids, hospitalizations
that are not surgery related, dietary changes, IV therapy treatments, and other medication
treatments (Conrad et al., 2014; Laass et al., 2014; Peyrin-Biroulet et al., 2016). The treatments
can be physically and emotionally challenging, and researchers are beginning to use a trauma
lens to consider whether the physical and emotional aspects of IBD are related to traumatic stress
1

reactions. This study examined the relationships between disease impact and post-traumatic
stress disorder (PTSD) symptomology of patients with IBD.
Measuring Severity of IBD
Measuring the severity of IBD is a complex process, with little consensus on what
constitutes mild, moderate, or severe cases. This is partially because there is an extensive scope
of biopsychosocial factors that significantly influence patients’ experience of having IBD
(Fuller-Thomson & Sulman, 2006). The literature suggests three main domains that are relevant
to the evaluation of disease severity in UC and CD. These include the impact of the disease on
the patient, the burden of the disease, and the disease course (Peyrin-Biroulet et al., 2016).
Impact of the disease includes factors such as the clinical symptoms, quality of life, and fatigue
and disability; the term burden refers to measurable inflammatory burdens such as C-reactive
proteins, mucosal lesions, and extent of disease; and finally, disease course includes the
structural damage, any history of resection, the number of flares experienced and any
extraintestinal manifestations (Peyrin-Biroulet et al., 2016).
Although it may initially seem that the most profound impact on patients comes from the
physical symptoms of IBD, literature suggests there is a connection between the physically
measured severity of the illness (inflammatory levels, physical symptomology etc.) and various
aspects of mental health.
As this study sought to explore IBD from the patients’ perspectives, severity was
measured using both clinical symptoms of the disease, which would include aspects of impact,
burden and disease course as defined above, and a measure of IBD-related worry and concerns
that allows assessment of the emotional impact of the disease. Examining severity in these two
ways aligns more closely with the above literature by capturing a wider perspective of impact.
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The Role of Stress and PTSD in IBD
The literature suggests that stress can be both a result of the medical treatments and
regimen associated with IBD and a triggering and exacerbating factor in relation to the course
and symptoms of IBD (Camara et al., 2009; Hisamatsu et al., 2007; Levenstein et al., 2000
Maunder & Levenstein, 2008; Mawdsley, Macey, Feakins, Langmead, & Rampton, 2006).
Biologically, symptoms are exacerbated by stress through both central and peripheral
corticotrophin-releasing factor (CRF) systems. These systems have the potential to regulate
homeostasis in the gut, and during times of stress they have been found to act in a way that
influences IBD physiopathology (e.g., bloody stools, weight loss; Camara, Ziegler, Begre,
Schoepfer, & von Kanel, 2009; Hisamatsu et al., 2007; Levenstein et al., 2000; Maunder &
Levenstein, 2008; Mawdsley, Macey, Feakins, Langmead, & Rampton, 2006). Among studies of
UC patients, the relationship between stress and symptom flares is clear. Acute stress can induce
a systemic and mucosal pro-inflammatory response that contributes to flare-ups of symptoms,
while long-term stress was shown to triple the chance of a flare-up within eight months
(Levenstein et al., 2000; Mawdsley et al., 2006). Further, high levels of perceived stress in
general was associated with increased flares (Levenstein et al., 2000).
Researchers are also beginning to attend to the stress or trauma that results from living
with serious acute and chronic diseases (Edmondson 2014; Jackson et al., 2016; Levenstein et
al., 2000; Sajadinejad et al., 2012) and are using post-traumatic stress responses and PTSD as a
framework for understanding the experiences of those living with serious medical conditions.
PTSD is a debilitating psychiatric disorder that is often considered a reaction to extremely
stressful, specific events, such as combat, natural disaster, and terrorism (Stam, 2007). However,
PTSD is being expanded to include other stressful life events such as medical illness. PTSD that
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is subsequent to life-threatening medical events has been studied in cancer, stroke, and acute
coronary patients, and it has been found that 12-25% of these patients live with diagnosed PTSD
(Edmondson, 2014; Edmondson & Cohen, 2013; Konrad et al., 2017). Furthermore, at least 20%
of intensive care unit (ICU) survivors experience clinically significant symptoms of PTSD
during the first year following discharge. Although researchers have started to address the
relationships between acute medical events and PTSD, the association between chronic illnesses
and PTSD symptomology had not yet been explored.
The Enduring Somatic Threat Model
Edmondson (2014) proposed the enduring somatic threat model (EST) to address the
differences between PTSD resulting from a past, discrete external event and PTSD that is
experienced due to the acute manifestation of a chronic illness. He argued that there are key
differences between the two in patients’ perceptions and the manifestations of PTSD symptoms.
Specifically, Edmondson (2014) argued that in contrast to discrete/external trauma that occurred
in the past, medical trauma is perceived as an ongoing event of somatic origin that is recalled
whenever attention is directed towards the body. Patients with medical illnesses need to be
vigilant regarding signs of disease in the body so they can seek out proper treatment
(Edmondson, 2014). However, this necessary vigilance can easily become debilitating
hypervigilance. Thus, the ramifications of PTSD symptoms due to a medical condition might
differ from those caused by discrete/external trauma because of the necessity of being vigilant to
signals of threat.
Edmondson (2014) described hyperarousal as a PTSD symptom that is highly prevalent
among patients following medical events. In survivors of discrete/external traumatic events,
hyperarousal symptoms are distressing physiological responses that can include sleeplessness,
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irritability, and hypervigilance to threat cues. But with medical conditions, physicians often ask
patients to be aware of their bodies for signs of reoccurring disease in order to enhance chances
of positive outcomes through early detection and treatment. As such, patients who have chronic
conditions are often in a state of body vigilance for an extended period of time. Being in this
extended state of hypervigilance makes the population vulnerable to symptoms of hyperarousal.
The current study included a specific focus on levels of body vigilance in addition to general
PTSD symptoms.
According to Jackson et al. (2016), patients with acute illnesses possess unique
constellations of symptom characteristics of PTSD, the most prevalent of these being avoidance
and re-experiencing. In general, expression of trauma symptoms in this population includes
avoidance of medical clinics, hospitals, and medical procedures; intense future-oriented concerns
about the reemergence of illness; hypervigilant preoccupation with somatic symptoms;
preoccupation with thoughts or delusional memories from hospitalizations; social disengagement
and isolation related to fear of getting sick; refusal to watch medically-oriented news or
television; and reactivity to noises similar to those in ICUs such as beeping. Among medical
populations, avoiding the medical condition associated with the trauma can lead to poor health
outcomes, poor quality of life, and increased mortality (Edmondson, 2014), giving greater weight
to the negative consequences of avoidant behaviors.
Jackson et al. (2016) described re-experiencing symptoms as being focused on enduring
threats of the reoccurrence of the illness and current functional decline. They also described reexperiencing symptoms as fearfulness of attending medical appointments and fear of returning to
clinics that symbolize the possibility of being admitted to the ICU again (Jackson et al., 2016).
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This description highlights the relationship between avoidance and re-experiencing as avoidance
may occur as a result of the fear of re-experiencing symptoms.
The EST model is too new to have received extensive examination, however, in an
investigation of acute coronary syndrome (ACS) patients, it was found that participants who
endorsed greater levels of emergency department threat perceptions during the event and
ongoing cardiac threat following the event were more likely to endorse symptoms congruent
with PTSD diagnosis than those who only endorsed perceived threat during the event. This
indicates that ongoing body vigilance does indeed play a key role in symptom exacerbation and
the potential for development of PTSD (Meli et al., 2017). Given the necessity for patients to
remain vigilant for symptoms, especially among UC and CD patients who are threatened by
acute flare-ups, it is therefore likely that this population will be at a higher risk for increased
PTSD symptom endorsement and the potential development of diagnosable PTSD. However, the
prior literature has not established the presence of PTSD symptoms in this population, nor
whether IBD is associated with specific constellations of symptoms of PTSD. The current study
extended Edmonson’s (2014) EST model to patients with IBD, and examined the associations
between IBD severity and trauma symptom constellations, specifically trauma symptoms of body
vigilance, re-experiencing, and avoidance.
Posttraumatic Growth
Although traumatic events are viewed as negative, a growing body of literature highlights
positive changes that might occur as a result of experiencing traumatic events. This phenomenon
is termed posttraumatic growth (PTG) (Ackroyd et al., 2011; Linley & Joseph, 2004; PurcStephenson, 2014). PTG is defined as “positive psychological changes that occur as a result of
one’s struggle to cope with trauma or a major life crisis” (Purc-Stephenson, 2014, p. 10). After a
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traumatic event life, changes can occur in five domains: personal strength, social relationships,
appreciation for life, identification of new possibilities, and changes to spirituality (Walsh et al.,
2018). Similar to Edmondson’s position that trauma resulting from an acute medical event differs
from trauma resulting from a discrete external past event, some literature on PTG argues that the
growth experienced as a result of physical trauma differs from the PTG that is seen from other
types of trauma. In particular, Walsh et al. (2018) stated that physical trauma can facilitate a
reconnection to the body, which leads to an enhanced appreciation of the body, increased care of
one’s body, and positive health behavior changes.
In their review of 57 studies pertaining to PTG and physical illnesses, Hefferon, Grealy,
and Mutrie (2009) noted that there was little information on the positive benefits reported from
survivors of physical illnesses, and the PTG experienced as a result of physical trauma is not
assessed by most PTG measures. Overall, they found that receiving a diagnosis led to patients
engaging in positive and negative reappraisal of their lives, restructuring of previous priorities,
reappraisal and improvement of relationships, prioritization of health and subsequently increased
health behaviors, new awareness of their bodies, new appreciation for life, and meaning making
through guiding others with the same illness. Additionally, a sense of connection to the physical
self was attributed to learning about the body by researching the illness with which the
participant was diagnosed. This study’s findings illustrate the potential importance of further
study of how PTG might buffer the stress resulting from IBD.
PTG has been shown to be an effective moderating variable among cancer populations.
Among young adult cancer survivors, PTG moderated the relationship between intrusive
thoughts and adjustment, and, among a separate population of breast cancer survivors, PTG
moderated the relationships between posttraumatic stress symptoms (PTSS) and both depression
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and impaired quality of life (Morrill et al., 2008; Park, Chmielweski, & Blank, 2010).
Furthermore, literature shows that IBD patients are able to identify at least one way in which
IBD had a positive effect on their lives, and that IBD patients tend to possess high levels of PTG
overall (Purc-Stephenson, Bowlby, & Qaqish, 2015; Purc-Stephenson, 2014; Tedeschi &
Calhoun, 1996).
Based on previous literature, it was expected that PTG would moderate the relationship
between the impact of IBD (clinical symptoms and IBD-related concerns) and symptoms of
PTSD. PTG is a malleable characteristic that can be enhanced (Morrill et al., 2008; Park et al.,
2010; Purc-Stephenson, 2014). If it does serve as a moderator, this would have important clinical
implications for working with patients diagnosed with UC and CD.
Remission
Remission from IBD can be defined as a decrease or disappearance of the symptoms of
IBD. Remission periods among IBD patients vary widely, lasting anywhere from a few days to
years, and flare-ups can also vary in their longevity and severity of symptoms (Subramanian &
Tridafilopoulos, 2016). Literature supports that remission positively influences the lives of
patients with IBD (Baumgart & Sandborn, 2012; Camara, Ziegler, Begre; Conrad et al., 2014;
Schoepfer, & von Kanel, 2009). A study of the role of remission on quality of life among UC
and CD patients found that the psychological well-being among IBD patients in long-standing
remission was similar to that of the general population (Simren et al.,2002). Additionally, among
patients with CD, remission was found to be associated with higher quality of life, mental and
physical functioning, and lower hospitalization and surgery rates over time (Lichtenstein, Yan,
Bala & Hanauer, 2003).
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The EST model assumes that medical patients are more vulnerable to being aware of an
ongoing threat to their mortality, which subsequently drives patients’ PTSD symptoms. Even
though UC and CD are not curable, patients do experience remission, and remission has a
positive impact on patients. Therefore, remission may reduce the perceived level of enduring
threat, and whether or not a patient is currently in remission may moderate the relationship
between the impact of the disease and current PTSD symptoms. Additionally, if patients feel
they are likely to remain in remission (i.e., they have confidence that symptoms will not reoccur
for a lengthy period of time, or that the recurrence will not be severe), then their mortality is less
likely to be threatened, and they would experience fewer PTSD symptoms. Although it may
seem obvious that current remission status or expectations about remission would serve to
moderate the negative effects of IBD severity, this idea has yet to be tested.
Purpose and Hypotheses
In order to gain a better understanding of aspects of UC and CD that may predict
symptoms of PTSD, this study had several purposes. First, in order to extend Edmonson’s EST
model to IBD, the study explored how many participants met the clinical criteria of being at risk
for developing PTSD, based on the established cut-off score of 33 on the Posttraumatic Stress
Disorder Checklist for DSM-5 (PCL-5).
Second, the study examined PTSD symptom clusters endorsed by the participants and
explored the relative strength of the correlations between IBD severity in terms of clinical
symptoms and IBD-related worry and concerns and constellations of PTSD symptoms and body
vigilance. This question tests the EST model by examining the correlation between IBD severity
and vigilance given Edmondson’s theory of the connection between illness and hypervigilance.
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Third, the study examined the relationships between aspects of disease impact as assessed
by measures of clinical symptoms and IBD-related concern, and symptoms of PTSD including
body vigilance, and whether these relationships were moderated by PTG. We hypothesized that
PTG would moderate the relationship between the impact of IBD and PTSD symptomology such
that, at greater levels of PTG, the relationships between the impact of IBD and PTSD
symptomology (total scores on PTSD symptom measure and a measure of body vigilance) would
be weaker.
Finally, the study examined the relationships between the IBD severity and symptoms of
PTSD and body vigilance and whether these relationships were moderated by remission status
(Hypothesis 4), as well as patients’ expectations of their remission (Hypothesis 5). We
hypothesized that current remission status would moderate the relationship between the impact
of IBD and PTSD symptomology such that, as patients endorsed being in remission, the
relationship between the impact of IBD and PTSD symptomology would be weaker. We also
hypothesized that patients’ expectations of their remission would moderate the relationship
between the impact of IBD and PTSD symptomology such that as patients’ confidence in their
remission longevity increased, the relationship between the severities of IBD and PTSD
symptomology would be weaker.
As some participants may have experienced other types of trauma that would influence
their scores on the measure of PTSD symptomology, a measure of other non-illness related
trauma was entered as a control variable in the regression analyses testing the moderation
hypotheses. Figure 1 shows the hypothesized model.
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IBD Impact
Clinical Symptoms (PSCCAI)
Quality of Life (RFIPC)

PTSD Symptoms
(PCL-5)
Hyper arousal (BVS)

Moderators
Posttraumatic Growth
Flare-up Status
Expected Remission
Figure 1. Hypothesized Model of Moderations
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Method
Participants
Participants for this study included a non-random sample of 313 adults, age 18 or older
who self-identified as having a diagnosis of either UC (n = 140, 44.7%) or CD ((n = 173,
55.3%). Participants’ age ranged from 18-70. (M = 33 , SD = 11 ). The majority of the sample
identified as female (75.1%) with 24.3% as male and .6% choosing not to respond. Participants
also reported whether or not they were currently in remission or experiencing a flare-up of
symptoms and their expectations for the likelihood of experiencing a flare-up in the next two
months on a likert scale. These questions served as the measures of the remission-related
variables in the analyses. Additional demographic data are presented on Table 1.
Table 1
Participant Demographic Data (N = 313)
Measure

n

%

290

92.7

African-American

1

.3

Hispanic/Latino/a

4

1.3

Asian/Asian American

5

1.6

Biracial or Multiracial

8

2.6

Other

5

1.6

Do not identify as having a disability

146

46.6

Identify, no benefits, no accommodations

78

24.9

Ethnicity
White/Caucasian

Disability Status
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Table 1 Continued
Participant Demographic Data (N = 313)
Measure

n

Identify, applying for disability benefits, asks 8

%
2.6

for accommodations
Identify, receives disability benefits

28

8.9

Unemployed, not looking for work

37

11.8

Unemployed, looking for work

11

3.5

Seasonally (<20hrs/week)

18

5.8

Part Time (20-34hrs/week)

32

10.2

Full time (35+ hrs/week)

141

45.0

Student employed part time

30

9.6

Student employed full time

22

7.0

Student unemployed looking for work

4

1.3

Student unemployed not looking for work

18

5.8

7

2.2

Received GED

7

2.2

High School Graduate

37

11.8

Some college did not receive degree

55

17.6

Associates Degree

26

8.3

Employment Status

Education Level
Some high school did not graduate or receive
GED
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Table 1 Continued
Participant Demographic Data (N = 313)
Measure

n

%

Bachelor’s Degree

89

28.4

Some graduate coursework

23

7.3

Master’s Degree or equivalent

58

18.5

Doctoral Degree/Professional Degree

11

3.5

Measures
The Patient Simple Clinical Colitis Activity Index (P-SCCAI). IBD clinical severity
was assessed with the P-SCCAI, which was adapted from the original Simple Clinical Colitis
Activity Index (SCCAI) into a 12-item questionnaire that could be completed by patients (rather
than medical personnel). The P-SCCAI asks about symptoms across several domains including
bowel frequency during the day, bowel frequency at night, blood in stool, general well-being,
urgency of defecation, and extracolonic features. Response options vary across questions.
Responses are summed with higher numbers indicating more current severity and possible scores
range between 0 - 27. When correlated with the original SCCAI, the Spearman’s Rho between
the two measures was .79, indicating a strong correlation. The patients’ and clinicians’
agreement in judging whether UC was active or in remission was 87% (Bennebroek Evertsz et
al., 2013).
The Rating Form of IBD Patient Concerns (RFIPC). The RFIPC is a 25-item selfreport measure that assesses IBD-specific worries and concerns. Participants rate their level of
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concern with each item on a scale of 0-100, with 0 being not at all and 100 being a great deal. A
total score is determined by averaging all of the responses given. Test-retest reliability over a
three-month period was .79 and the Cronbach’s alpha was .95 (Hjortswang, Strom, Almeida, &
Almer, 1997).
The Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5). The PCL-5 is a 20item updated version of the Posttraumatic Stress Disorder Checklist (PCL) designed to address
the PTSD diagnostic criteria listed in the DSM-5. In the PCL-5, additional items were added to
address three new Posttraumatic Stress Disorder (PTSD) symptoms of blame, negative emotions,
and reckless behavior. Items on the revised scale are scored on a rating scale of zero to four, with
the intent that the lowest possible score could be a zero. The PCL-5 item scores can be summed
to generate a continuous measure for total PTSD symptom severity as well as scores for
symptom criterion clusters that include: re-experiencing, avoidance, negative alterations in
cognition and mood, and trauma-related alterations in arousal and reactivity. The PCL-5 total
score was shown to have strong test-retest reliability, r = .82, over the course of 1 week.
Additionally, the internal consistency, convergent and discriminant validity, and structural
validity of PCL-5 scores were strong. Research suggests that a cutoff score of 31-33 is indicative
of probable PTSD with a recommendation to use a cut-off score of 33 when making a
provisional diagnosis in order to minimize false positives (Blevins, Weathers, Davis, Witte, &
Domino, 2015).
Body Vigilance Scale (BVS). The BVS is a 4-item measure designed to assess
attentional focus to internal bodily sensations (Schmidt, Lerew, & Trakowski, 1997). The first
three items assess the degree of attentional focus (“I am the kind of person who pays close
attention to internal bodily sensations”), perceived sensitivity to changes in bodily sensations (“I
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am very sensitive to changes in my internal bodily sensations”), and the average amount of time
spent attending to bodily sensations (“On average, how much time do you spend each day
‘scanning’ your body for sensations (e.g., sweating, heart palpitations, dizziness)?”).
Participants are instructed to rate how much they attend to each of these sensations from not at
all or never (0) to extremely or constantly (10). A fourth item identifies 15 distinct sensations
including all of the symptoms of panic attack as defined by the DSM-IV-TR (Schmidt, Lerwe &
Trakowski, 1997) and asks how much attention is paid to each of the sensations (0 – 10). Ratings
for the 15 sensations are averaged to yield one overall score for Item 4. The BVS total score is
the sum of these four items and can range between 0 and 40. Principal component analysis of
BVS items indicated a single factor (Schmidt, Lerew, & Trakowski, 1997; Vujanovic,
Zvolensky, Bernstein, Feldner & McLeish, 2007). Estimates of internal consistency and testretest reliability are good, with an average Cronbach’s alpha of .83 in non-clinical samples and a
5-week test-retest coefficient of r =.68 (Schmidt, Lerew, & Trakowski, 1997).
The Posttraumatic Growth Inventory (PTGI). The PTGI is 21-item self-report
measure that assesses PTG over five factors (relating to others, new possibilities, personal
strength, spiritual change, and appreciation of life). Participants rate their experience of change
on a 5-point Likert scale (0 = I did not experience this change as a result of my crisis to 5 = I
experience this chance to a very great degree as a result of my crisis). The items are summed to
yield a total growth score ranging from 0 to 105. Higher scores are indicative of greater levels of
growth. PTGI sores were shown to have good internal consistency (coefficient alpha = .90) and
test-retest reliability over the course of two months (r = .71) (Tedeschi & Calhoun, 1996).
The Brief Trauma Questionnaire (BTQ). The BTQ is a 10-item self-report measure to
assess Criterion A of the PTSD diagnostic criteria of the DSM-V and was used as a statistical
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control for non-medical trauma (so the single question regarding life-threatening illness was not
included). It is derived from the Brief Trauma Interview that assesses whether an individual
experienced a traumatic event that met the DSM-IV criteria (Schnurr, Spiro, Vielhaur, Findler &
Hamblen, 2002). The BTQ assesses traumatic events including physical assault, natural disasters,
medical illness, and unwanted sexual contact. Participants respond to whether or not the event
happened to them, whether they thought their lives were in danger or they would be seriously
injured, and if they were seriously injured. Not all events include the second (life in danger) or
third (serious injury) option. Scores can range between 0 and 23 (not including the medical
question) with higher scores indicating more trauma. Interrater reliability kappa coefficients for
the presence of trauma that met Criterion A or trauma exposure according to the DSM-IV were
above .70 (range .74-1.00) for all events except illness (.60) (Koenen, DeVivo, Rich-Edwards,
Smoller, Wright & Purcell, 2009; Schnurr, Spiro, Vielhaur, Findler & Hamblen, 2002).
Procedures
The study was reviewed and approved by the University IRB prior to data collection. The
online survey was administered via a link to a Qualtrics survey. This link was distributed to
social media IBD support groups on Instagram, Facebook, and Reddit. The link was also made
into a QR code that was placed (with permission) in Gastroenterology offices, and in various
community bathrooms. Participants who completed the survey were encouraged to send it to
other individuals who met the study criteria (snowball sampling).
The survey began with the demographics and disease description questionnaire. Leong and
Austin (2006)’s description of item ordering advises that items that come first in a survey should
be directly related to the purpose, and they indicate that some participants may be more
comfortable responding to items that are objective at the beginning. Following these initial
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questions, participants answered the BVS followed by the PCL-5, the PTGI, the BTQ, the PSCCAI, and finally the RFIPC.
Results
Preliminary Analyses
Data analysis began with an examination of missing data to ensure that enough data were
present to conduct the later analyses. Cases that were missing 20% or more of data on any
instrument were removed from the data set, which led to the loss of five participants (Peng,
Harwell, Liou, & Ehman, 2006). Additionally, the data were checked for inattentive responses
through the use of attention check items in the survey. Inattentive response checks resulted in
removing three participants from the final sample. Data were analyzed for normality using SPSS
version 24. Skewness and kurtosis ranged between .534 and -.974, and data were assumed to be
normally distributed. Univariate outliers were examined using z scores +/-3.00. Mahalanobis
distances among the variables were examined to evaluate multivariate outliers. In total, 17
multivariate outliers were identified and removed, yielding a total final sample size of 313.
Prior to conducting main analyses, differences between the UC and CD patients on all the
study variables were examined using one-way analysis of variance (ANOVA). There were no
significant differences between the two groups on any study variables, so they were combined
for all subsequent analyses. Descriptive statistics, and correlation coefficients among study
variables were computed and are presented on Table 2.
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Table 2
Means, Standard Deviations and Intercorrelations for the Total Sample (N = 313)
1
2
3
4
5
6

7

8

9

10

11

12

1. BVS

.93

2. PCL-5

.35**

.93

3. Avoidance

.28**

.71**

.84

4. Re-Exp.

.35**

.86**

.62**

.87

5. Neg Alt.

.26**

.92**

.54**

.67**

.89

6. React.

.33**

.88**

.53**

.66**

.75**

.79

7. PTGI

.14*

-.04

.04

.07

-.13*

-.03

.95

8. BTQ

.07

.16**

.07

.14*

.15**

.16**

.07

.48

9. P-SCCAI

.13*

.39**

.21**

.29**

.37**

.41**

-.08

.17**

.67

10. RFIPC

.26**

.47**

.26**

.44**

.42**

.44**

.07

.09

.36**

.92

11. R.Status

-.07

-.24**

-.08

-.11*

-.28**

-.26**

.05

-.12*

-.58**

-.21**

12. R.Expect.

-.11

-.36**

-.16**

-.26**

-.36**

-.35**

.20**

-.10

-.54**

-.26**

.59**

Means

26.78

26.08

2.75

6.18

9.42

7.72

51.97

.88

5.49

51.61

.42

2.50

SD

7.01

16.24

2.23

4.71

6.86

4.92

24.22

1.16

3.87

20.29

.50

.97

Note: BVS=Body Vigilance Scale; PCL-5 = The Posttraumatic Stress Disorder Checklist for DSM-5; Re-Exp = Re-experiencing; Neg.Alt =
Negative Alterations in Mood; React = Reactivity; PTGI = Posttraumatic Growth Inventory; BTQ=Brief Trauma Questionnaire; P-SCCAI = The
Patient Simple Clinical Colitis Activity Index; RFPIC = The Rating Form of IBD Patient Concerns ;R.Status = Remission Status; R. Expect. =
Remission Expectations. Cronbach’s alpha coefficients are presented on the diagonal.
* p < .05; **p < .01.
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Primary Analyses
The first hypothesis of this study examined the overall endorsement of PTSD symptoms
among IBD patients. PTSD symptoms were assessed using scores on the PCL-5. A score of 33 or
higher on the PCL-5 is used to indicate clinically significant endorsements of PTSD symptoms
(National Center for PTSD) and would justify subsequent interviewing and assessment to
determine if a full PTSD diagnosis is appropriate. In total, 32.8% (n = 103) of participants
received a score of 33 or higher; the average score in the whole sample was 26.08 and the
standard deviation was 16. Hypothesis 1 was supported in that there was a substantial subset of
the sample that scored above an established cut-score for PTSD symptoms.
The second hypothesis examined PTSD symptom clusters endorsed by participants.
Correlations among the variables indicated that scores on the measure of clinical symptoms of
IBD were most strongly correlated with PTSD symptom clusters of reactivity (r =.41), negative
alterations in cognition and mood (r = .37), and re-experiencing (r = .29). Scores on the measure
of IBD related worries and concerns were most strongly correlated with symptoms of reexperiencing (r =.44) and reactivity (r = .44) and negative alterations in cognition and mood (r =
.42). Finally, a significant correlation was found between clinical symptoms of IBD and
avoidance (r = .21). Calculating the difference between the correlations (Lee & Preacher, 2013)
indicated that the correlations between the measure of clinical symptoms of IBD and reactivity
and negative alterations in mood were significantly stronger than between correlations between
the measure of clinical symptoms of IBD and avoidance or re-experiencing. Similarly, the
correlations between the endorsements of IBD related worries and concerns and reactivity, re-
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experiencing, and negative alterations in mood were significantly stronger than between the
correlation between IBD related worries and concerns and avoidance.
Moderation Analyses
The SPSS PROCESS macro was used to test the moderation hypotheses. PROCESS is a
computational procedure for SPSS that implements moderation analyses using an ordinary least
squares regression framework (Hayes, 2018). The PROCESS macro for simple moderation has
been found to be advantageous as it includes the estimation of bias-corrected bootstrap
confidence intervals to test for significance (Hayes, 2018). The third hypothesis examined
whether posttraumatic growth would moderate the relationship between impact of IBD and
PTSD symptomology. Four separate analyses were conducted in which both aspects of the
impact of IBD (i.e., P-SCCAI scores which measure clinical symptoms and RFIPC scores which
measure IBD related worries and concerns), posttraumtic growth, and their interactions were
used to predict the overall scores on the measure of PTSD symptoms and measure of body
vigilance. All analyses controlled for previous non-medical trauma using scores on the BTQ, a
measure of prior trauma.
First, clinical symptoms of IBD, posttraumatic growth, and their interaction terms were
used to predict PTSD symptom total scores and the measure of body vigilance. The P-SCCAI
measure of clinical symptoms was a significant predictor of both PTSD symptom total scores, b
= 1.56 t(308) = 7.01, p < .001, and body vigilance, b = .25, t(308) = 2.43, p < .05. However,
neither posttraumatic growth scores nor the interaction of IBD clinical symptoms and
posttraumatic growth predicted total scores on the measure of PTSD symptoms. While
posttraumatic growth scores were predictive of body vigilance, b = .04, t(308) = 2.70, p < .01,
the interaction of posttraumatic growth and clinical symptoms of IBD was not significant and
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posttraumatic growth did not moderate the effect of clinical symptoms of IBD on either measure
of trauma symptoms. Table 3 presents the results of these analyses.

Table 3
Moderation Analyses of Posttraumatic Growth on the Relationships between Clinical Symptom
Severity and PTSD Symptoms and Clinical Severity and Body Vigilance (N = 313)
PCL-5
Predictor

b

P-SCCAI

BVS

95% CI

t

b

95% CI

t

1.56

[1.12, 2.00]

7.01**

.25

[.05, .45]

2.43*

PTGI

-.01

[-.08, .06]

-.32

.04

[.01, .08]

2.70**

BTQ

1.35

[-.11, 2.81]

1.82

.20

[-.47, .88]

.59

P-SCCAI x

-.01

[-.03, .01]

-1.32

-.00

[-.01, .01]

-.37

PTGI
Note. PCL-5 Model: R2 = .17, F(4, 308) = 15.40, p < .001. BVS Model: R2 = .04, F(4, 308) =
3.47, p =.01. CI = confidence interval for b. PCL-5 = The Posttraumatic Stress Disorder
Checklist for DSM-5; BVS=Body Vigilance Scale; P-SCCAI = The Patient Simple Clinical
Colitis Activity Index; PTGI = Posttraumatic Growth Inventory; BTQ = Brief Trauma
Questionnaire.
** p < .01, * p < .05.

Second, scores on the measure of IBD related worries and concerns, posttraumatic
growth, and their interaction terns were used to predict PTSD symptom total scores and the
measure of body vigilance (BVS scores). The RFIPC measure of IBD related worries and
concerns was a significant predictor of both PTSD symptom total scores, b = .38 t(308) = 9.39, p
< .001, and body vigilance, b = .09 t(308) = 4.46, p < .001. However, neither posttraumatic
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growth scores nor the interaction of IBD related worries and concerns and posttraumatic growth
predicted PTSD symptom total scores. Posttraumatic growth scores were predictive of body
vigilance scores, b = .04, t(308) = 2.24, p < .05, but the interaction of posttraumatic growth and
IBD related worries and concerns was not significant and posttraumatic growth did not moderate
the effect of patient concerns scores on either measure of trauma symptoms. Table 4 presents the
results of these analyses. Hypothesis 3 that posttraumatic growth would moderate the
relationship between measures of the impact of IBD and trauma symptoms was not supported.
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Table 4
Moderation Analyses of Posttraumatic Growth on the Relationships between IBD Worries and
Concerns and PTSD Symptoms and IBD Worries and Concerns and Body Vigilance (N = 313)
PCL-5
Predictor

BVS

b

95% CI

t

RFIPC

.38

[.30, .45]

9.39**

.09

[.05, .12]

4.46**

PTGI

-.05

[-.12, .01]

-1.58

.04

[.00, .07]

2.24*

BTQ

1.70

[.33, 3.07]

2.44*

.21

[-.44, .86]

.64

.00

[.00, .00]

-.46

.00

[.00, .00]

-.77

P-SCCAI x

b

95% CI

t

PTGI
Note. PCL-5 Model: R2 = .24 F(4, 308) = 24.95, p < .001. BVS Model: R2 = .29, F(4, 308) =
7.16, p < .001. CI = confidence interval for b. PCL-5= The Posttraumatic Stress Disorder
Checklist for DSM-5; BVS=Body Vigilance Scale; RFPIC= The Rating Form of IBD Patient
Concerns; PTGI=Posttraumatic Growth Inventory; BTQ=Brief Trauma Questionnaire.
** p < .01, * p < .05.

The fourth hypothesis examined whether current flare-up status would moderate the
relationship between IBD impact and PTSD symptomology. Four separate analyses were
conducted in which both aspects of IBD impact (i.e., P-SCCAI scores and RFIPC scores),
current flare-up status, and their interaction terms were used to predict the overall scores on the
measure of PTSD symptoms and the measure of body vigilance. Current flare status was a
dichotomous variable with no current flare coded as 0 and current flare coded as 1.
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Clinical symptoms of IBD, current flare-up status, and the interaction term were used to
predict PTSD symptom total scores. Scores on the measure of clinical symptoms of IBD
positively predicted PTSD symptom total scores, b = 1.73, t(307) = 6.18, p < .001. Current flareup status did not predict PTSD symptom scores, however the interaction of IBD clinical
symptom scores and current flare status was predictive of the overall PTSD symptoms scores , b
= -1.33, t(307) = -2.48, p < .05. If participants endorsed they were currently experiencing a flare,
the participants’ PTSD symptom scores increased by .96 for every one unit increase in IBD
clinical symptom scores. However, if participants endorsed they were not currently experiencing
a flare, their PTSD symptom scores increased by 2.29 for every one unit increase in IBD clinical
symptom scores, indicating that the increase in IBD symptoms had a stronger relationship to
trauma symptoms for individuals who did not endorse experiencing a flare. Figure 2 shows the
interaction. The regression model for body vigilance was non-significant. The results of these
analyses are presented on Table 5.
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Table 5
Moderation Analyses of Remission Status on the Relationships between Clinical Severity and
PTSD Symptoms and Clinical Severity and Body Vigilance (N = 312)
PCL-5
Predictor

b

P-SCCAI
R. Status
BTQ
P-SCCAI x

BVS

95% CI

t

b

95% CI

1.73

[1.18, 2.28]

.58

t

6.18**

.21

[-.05, .46]

1.57

[-3.54, 4.69]

.28

.-.11

[-2.04, 1,82]

-.11

1.29

[-.15, 2.74

1.76

.26

[-.42, .94

.75

-1.33

[-2.39, -.27]

-2.48*

.23

[-.27, .72]

.89

PTGI
Note. PCL-5 Model: R2 = .18, F(4, 307) = 16.77, p < .001. BVS Model: R2 = .02, F(4, 307) =
1.77, p =.13. CI = confidence interval for b. PCL-5 = The Posttraumatic Stress Disorder
Checklist for DSM-5; BVS = Body Vigilance Scale; P-SCCAI = The Patient Simple Clinical
Colitis Activity Index; R. Status = Remission Status; BTQ = Brief Trauma Questionnaire.
** p < .01, * p < .05.

40
35
PCL-5 Scores

30
25
20

No Flare Endorsed

15

Flare Endorsed

10
5
0
Low PSCCAI

High PSCCAI

Figure 2. Interaction effect of IBD clinical impact (P-SCCAI) and current remission status on
traumatic stress symptoms (PCL-5)
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Scores on the RFIPC measure of IBD related worries and concerns, current flare-up
status, and the interaction term were used to predict PTSD symptom total scores. IBD related
worries and concerns b = .35, t(308) = 8.70 p < .001 and current flare-up status, b = 4.37, t(308)
= 2.62 p < .01 predicted PTSD symptom total scores. The interaction of IBD related worries and
concerns and current flare status was not predictive of the overall PTSD symptom scores so
current flare status did not moderate the relationship between patient concerns and PTSD
symptomology. The similar regression model predicting body vigilance was significant. IBD
related worries and concerns, b = .09, t(307) = 4.70 p < .001, and the interaction of IBD related
concerns and current flare status, b = -.09, t(308) =.11 p < .05 was predictive of body vigilance
scores. If participants were currently experiencing a flare, for every one unit increase in IBD
related worries and concerns, their body vigilance scores increased by .14. When participants
were not experiencing a current flare, every one unit increase of IBD related worries and
concerns was associated with an increase in body vigilance scores of only .06. The results of the
analyses are presented on Table 6. Figure 3 displays the interaction. Hypothesis 4 was partially
supported in that current remission status moderated the relationships between clinical severity
as measured by the PSCCAI and PTSD symptomology and between IBD-related patient
concerns body vigilance although the moderating effect of remission status on PTSD
symptomology was in the opposite direction than hypothesized.
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Table 6
Moderation Analyses of Remission Status on the Relationships between IBD Worries and
Concerns and PTSD Symptoms and IBD Worries and Concerns and Body Vigilance (N = 312)
PCL-5
Predictor

BVS

b

95% CI

t

.35

[.27, .43]

8.70**

.09

[.05, .13]

R. Status

4.37

[1.09, 7.65]

2.62*

.09

[-1.48, 1.66]

.11

BTQ

1.46

[.09, 2.82

2.10*

.26

[-.39, .92]

.79

.06

[-.10, .23]

.76

.08

[.01, .16]

2.13*

RFIPC

P-SCCAI x

b

95% CI

t
4.70**

PTGI
Note. PCL-5 Model: R2 = .26, F(4, 307) = 26.74, p < .001. BVS Model: R2 = .08, F(4, 307) =
6.97, p < .001. CI = confidence interval for B. PCL-5= The Posttraumatic Stress Disorder
Checklist for DSM-5; BVS=Body Vigilance Scale; RFPIC= The Rating Form of IBD Patient
Concerns; R. Status = Remission Status; BTQ=Brief Trauma Questionnaire.
** p < .01, * p < .05.
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Figure 3. Interaction effect of IBD psychological impact (RFIPC) and current remission status
on body hyper-vigilance (BVS)
The fifth and final hypothesis addressed whether patients’ expectations for their
remission (i.e., expectation that they would experience a flare-up within the next two months)
moderated the relationship between the impact IBD and PTSD symptomology. Four separate
analyses were conducted in which both aspects of the impact of IBD (i.e., P-SCCAI scores and
RFIPC scores), remission expectations, and their interaction terms were used to predict the
overall score on the measure of PTSD symptoms and body vigilance, controlled by scores on the
BTQ, a measure of prior trauma.
Clinical symptoms of IBD, patients’ expectations of remission, and the interaction term
were used to predict PTSD symptom scores. The overall model was significant. Clinical
symptoms of IBD b = 1.16, t(307) = 4.41, p < .001 positively predicted PTSD symptom scores,
while expectations of remission b = 3.44, t(307) = 3.38, p < .001 were found to negatively
predict PTSD symptom scores. Their interaction was not significant. When clinical symptoms of
IBD, patients’ expectations of remission, and their interaction were used to predict the overall
scores of body vigilance, the overall model was not significant. Expectations of remission did not
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moderate the relationships between clinical severity and trauma symptoms or body vigilance.
Table 7 displays the results of these analyses.

Table 7
Moderation Analyses of Remission Expectations on the Relationships between Clinical Severity
and PTSD Symptoms and Clinical Severity and Body Vigilance (N = 312)
PCL-5
Predictor

b

P-SCCAI

BVS

95% CI

t

b

95% CI

t

1.16

[.64, 1.67]

4.41**

.18

[-.06, .42]

1.44

R. Expect

3.44

[1.44, 5.44]

3.38**

.36

[-.59, 1.31]

.74

BTQ

1.33

[-.10, 2.76]

1.82

.25

[-.43, .93]

.72

P-SCCAI x

-.17

[-.63, .29]

-.72

.01

[-.20, .23]

.13

R. Expect
Note. PCL-5 Model: R2 = .19, F(4, 307) = 18.46, p < .001. BVS Model: R2 = .02, F(4, 307) =
1.71, p =.15. CI = confidence interval for B. PCL-5 = The Posttraumatic Stress Disorder
Checklist for DSM-5; BVS = Body Vigilance Scale; P-SCCAI = The Patient Simple Clinical
Colitis Activity Index; R. Expect. = Remission Expectations; BTQ = Brief Trauma
Questionnaire.
** p < .01, * p < .05.

IBD related worries and concerns patients’ expectations of remission, and their
interaction were used to predict scores on the measure of PTSD symptoms. The overall model
was significant. IBD related worries and concerns, b = .33, t(307) = 8.21, p < .001, and
expectations of remission, b = 3.94, t(307) = 4.73, p < .001, both predicted PTSD symptom total
scores. The interaction was also a significant predictor, b = .09 t(307) = 2.14, p < .05. When
participants endorsed low likelihood of experiencing a flare-up, for every 1 unit increase on the
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measure of IBD related worries and concerns, PTSD symptom scores increased by .23. When
participants endorsed medium likelihood of experiencing a flare-up, for every 1 unit increase on
the measure of IBD related worries and concerns, PTSD symptom scores increased by .33.
Finally, when participants endorsed high likelihood of experiencing a flare-up, for every 1 unit
increase on the measure of worries and concerns, PTSD symptom scores increased by .42. Table
8 shows the results of the regression analyses and Figure 4 displays the interaction. IBD related
worries and concerns, patients’ expectations of remission, and their interaction were used to
predict body vigilance scores. The overall model was significant. IBD related worries and
concerns, b = .33, t(307) = 8.21, p < .001, predicted body vigilance, however expectations of
remission did not. The interaction of remission expectations and IBD related worries and
concerns was also found to be non-significant (see Table 8). Hypothesis 5 was partially
supported in that expectations of remission moderated the relationship between IBD concerns
and PTSD symptomology.
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Table 8
Moderation Analyses of Remission Expectations on the Relationships between IBD Worries and
Concerns and PTSD Symptoms and IBD Worries and Concerns and Body Vigilance (N = 312)
PCL-5
Predictor

BVS

b

95% CI

.33

[.25, .40

8.21**

. 09

[.05, .12]

R. Expect

3.94

[2.30, 5.58]

4.73**

.25

[-.56, 1.06]

.61

BTQ

1.37

[.05, 2.69]

2.05*

.23

[-.43, .88]

.68

.09

[.01, .18]

2.14*

.03

[-.01, .08]

1.58

RFIPC

RFIPC x R.

t

b

95% CI

t
4.39**

Expect
Note. PCL-5 Model: R2 = .30, F(4, 307) = 33.37, p < .001. BVS Model: R2 = .08, F(4, 307) =
6.52, p < .001. CI = confidence interval for B. PCL-5 = The Posttraumatic Stress Disorder
Checklist for DSM-5; BVS = Body Vigilance Scale; RFPIC = The Rating Form of IBD Patient
Concerns; R. Expect.= Remission Expectations. BTQ = Brief Trauma Questionnaire.
** p < .01, * p < .05.
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Figure 4. Interaction effect of IBD psychological impact (RFIPC) and expectations of remission
on traumatic stress symptoms (PCL-5). High and low expectations of experiencing a flare are 1
SD above and below the mean respectively.
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Discussion
This study was the first to examine the prevalence of PTSD symptoms among IBD
patients and expand the EST model into a chronic illness population. The EST model postulates
that people living with acute medical illnesses (e.g., heart attack, stroke) experience
posttraumatic stress disorder symptoms. The current study sought to expand this model to
include IBD, which presents with similarly unpredictable periods of acuity, but is also a chronic
illness lasting over the course of patients’ lives. The EST model suggests that these individuals
might also experience a range of trauma symptoms. In a first empirical test of this supposition,
32.8% (n = 103) of participants with UC/CD received a score of 33 or higher on the PCL-5; a
score of 33 is the accepted indication of PTSD symptomology that is severe enough to warrant
additional assessment to determine whether a full PTSD diagnosis is appropriate. The average
score for the entire sample was 26.08. The relatively elevated average score and the subset of
participants who endorsed clinically significant levels of PTSD symptoms extends the EST
model by providing evidence that the chronic health condition of IBD is also associated with
significant trauma symptoms that deserve awareness from medical personnel.
The EST model proposed by Edmondson (2014) posits that trauma experienced
secondary to medical events leads to unique presentations of avoidance, hyperarousal and reexperiencing. Among medical populations, re-experiencing symptoms is often experienced by
patients as ongoing increased future-oriented worry driven by a threat to the patients’ well-being;
avoidance manifests as avoiding future treatment and nonadherence to medications as the
medication serves as a strong reminder of the illness; and hyperarousal is expressed through
hypervigilance of physical symptoms that can be warning signs for future or current threat.
Jackson et al. (2016) further examined PTSD symptom prevalence and constellations among
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acute illness patients, and supported the EST theory regarding unique presentations and
expanded this by finding that avoidance and re-experiencing were more prevalent in the acute
illness population. Although Jackson et al., reported information on the prevalence of symptoms
in acute illness populations, they did not examine the strength of the relationships between
severity of illness and symptoms. As such, in this study we went a step further and explored
these correlational relationships.
Although there were statistically significant relationships at the .01 level between scores
on a measure of clinical symptoms of IBD and each of the PTSD symptom domains, the
strongest relationships were between clinical symptoms of IBD and reactivity and negative
alterations in cognition and mood. Similarly, statistically significant relationships were found at
the .01 level between the IBD-related concerns and each PTSD symptom domain, however the
strongest relationships were with re-experiencing, reactivity, and negative alterations in
cognition and mood.
Examining the descriptions of these symptoms sheds light on potential reasons why these
symptoms were so strongly correlated with IBD impact. Symptoms of arousal and reactivity are
described as irritable behavior, taking risks, being “super alert,” feeling jumpy or startled, having
difficulty concentrating, and having difficulty falling or staying asleep (Blevins, Weathers,
Davis, Witte, & Domino, 2015). One possible explanation for the increased symptom
endorsement in this symptom cluster is the side effects of corticosteroids.
Corticosteroid medications such as Prednisone are commonly used to induce IBD
remission and are known to cause physically and emotionally disruptive side effects such as
sleep impairment, and mood swings (Steinberg & Charabaty, 2020). Furthermore, it is possible
that the experience of being under high amounts of stress, not feeling well, and going through
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medical procedures would likely to increase endorsements of irritability and difficulties with
concentration and sleep.
The measure of posttraumatic growth used in the current study, the PTGI, is one of the
most widely used measures of posttraumatic growth and the literature supports the theory that
posttraumatic growth would serve as an effective moderator in this population, However,
posttraumatic growth did not moderate the relationships between impact of IBD and PTSD
symptomology. This was unexpected. One possible explanation for the lack of moderation effect
might lie in the reference to a singular “crisis” on the PTGI. Given that UC and CD are life-long
illnesses and might include multiple smaller traumatic events over a long-term course,
participants might have been unsure of which “crisis” to reflect upon in their answers. Therefore,
in future research it would be beneficial to address this by having participants reflect on a past
specific traumatic aspect of their illness such as a significant surgery or their last serious flare.
A primary aspect of the theory of the EST model is that PTSD secondary to a medical
event represents a maladaptive fear response to a valid and ongoing threat to the individual’s
mortality. Among IBD patients, flare ups would be the manifestation of true threat as the patient
experiences increased clinical symptoms that raise awareness of their disease and might increase
their PTSD symptomology. In this study, we posited that participants’ remission status would
moderate the relationship between disease impact and PTSD symptomology, as would the
participants’ expectations of the length of their remission. It was hypothesized that being in
remission (not experiencing a current flare) would serve as a protective factor while currently
experiencing a flare would strengthen the relationship between IBD severity and stress
symptoms or vigilance. Interestingly, this was supported for the relationship between IBDrelated concern and body vigilance, but the opposite was true for the relationship between
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clinical severity and PTSD symptomology. When participants endorsed being in a flare state, the
relationship between their levels of IBD-related worries and concerns and levels of body
vigilance was stronger than for individuals who were currently in remission. On the other hand,
when participants endorsed being in remission, the relationships between clinical severity and
PTSD symptomology was strengthened.
These findings indicate the possibility that there is an increased level of stress symptoms
as patients experience more clinical symptoms and are waiting for the next flare to happen. IBD
is known to be a chronic, life long illness with an unpredictable course. Although we initially
hypothesized that being in remission would serve as a protective factor, it also makes sense that
remission could be a time in which patients are hyper aware of their bodies, increasingly
stressed, and increasingly activated in a way that might even exacerbate their symptoms. Patients
are aware that remission can end at any point, and experiencing greater reactivity and arousal
might be expected if they perceive that they might soon enter a flare period. This theory of
“waiting for the other shoe to drop” aligns well with the findings regarding expectations of
remission.
Patient’s expectations of their remission moderated the relationship between IBD-related
worry and concerns and PTSD symptomology in the expected direction. Even when participants
endorsed high levels of worries and concerns related to their IBD, patients who expressed
confidence that they would not experience another flare-up in the next two months endorsed
lower levels of trauma symptoms than those participants who endorsed less confidence in the
longevity of their remission. Following Edmondson’s model that symptoms are driven by an
ongoing threat to mortality, these findings suggest that in the IBD population there is increased
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awareness of threat taking place when patients lack confidence in the longevity of their remission
and see threats to their health in the form of flare ups as arising in the short term.
Clinical Implications
Overall, the results of the present study should raise awareness among medical and
mental health providers working with IBD patients. By reviewing the results of this study, more
specific recommendations for practice can be made. Given the endorsement of clinically
significant PTSD symptomology among participants in this study, all providers should be
vigilant for PTSD symptoms among this population, and when appropriate, connect patients with
the appropriate referrals to confirm a PTSD diagnosis. Furthermore, although many patients in
this sample did not endorse symptoms to the extent that they met the cut off score, any symptom
endorsement is significant in terms of the distress the patient is experiencing. Providers should
therefore take any symptom endorsement seriously and connect patients with appropriate
psychological follow up. In addition, it may be beneficial for providers to be vigilant for signs
of acute stress disorder immediately following major medical events such as surgery.
Medical providers should, of course, continue to strive to help patients achieve remission;
however, they should also be aware of the mental health impact remission can have on this
population. In this study we found that among patients in remission as their clinical symptom
endorsements increased, they endorsed PTSD symptoms at a higher rate than their peers who
were currently in a flare state. As stated above, this may be due to patients beginning to
experience a sense of waiting for the inevitable flare to happen and becoming stressed and
attentive to indicators that a flare up may begin. Providers working with this population could
talk with patients about their current practices for remaining vigilant for signs of threat,
encourage patients to monitor for symptoms in a normative manner, but also address the pitfalls
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of becoming overly reactive. Additionally, they might refer patients who are endorsing distress
to mental health professionals if they are not already doing so.
One avenue of mental health treatment that is beginning to show effectiveness is
engaging IBD patients in Acceptance and Commitment Therapy (ACT) (reference). In a recent
randomized controlled trial, IBD patients who went through a course of 8 weeks of ACT showed
improved levels of stress, quality of life and psychological health (Wynne et al., 2019). ACT
encourages patients to explore and adopt positive life values, and accept adverse experiences that
are a part of daily life. The acceptance aspect of ACT therapy is uniquely beneficial for IBD
patients, as it encourages patients to learn to live with adversities caused by their illness, and
cope effectively by engaging in behaviors that are in line with their values.
Limitations and Future Directions
As with all studies, there are several limitations to consider. One such limitation is the
lack of an IBD-related self-report measure that considers the totality of aspects of the disease
impact. As the literature states, severity is a complex concept involving various aspects of
disease ranging from medical history/course of disease, treatments used, psychological aspects,
and clinical symptoms. This study used a combination of two measures to address this deficit,
but in order to attain the most accurate picture of the impact of IBD on patients, it would be
helpful to be able to have a measure that captures the totality of the full range of IBD
experiences. Similarly, this study utilized cross-sectional data so the ability to make causal
attributions about relationships between variables is limited. It is possible that the relationship
between trauma symptoms and IBD impact, especially psychological impact in the form of
worry and concerns, are reciprocally causal.
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Posttraumatic growth is defined as one’s ability to make meaning and positive change
following a traumatic event. When considering the chronic, life-long nature of IBD, it is possible
this definition does not apply to this population. Unlike previously studied patients who
experienced acute medical events, patients with UC or CD are at increased risk for sudden,
unexpected relapse, and an unpredictable disease course. As a result, these patients may require a
wider definition of posttraumatic growth to include how one copes with a baseline level of lived
trauma. This way of conceptualizing posttraumatic growth would be unique to a chronic illness
population. If we consider Edmondson’s (2014) model and accept there are differences between
discrete external trauma and somatic threat, then posttraumatic growth might also differ for this
population. It will be beneficial for future work to continue to explore avenues of differences in
defining posttraumatic growth and how PTG may apply differently to chronic illness
populations.
There are limitations to the generalizability of the findings since the sample was
primarily Caucasian, female, and identified as persons who have health insurance. Aspects of
diversity, especially those related to access to medical care and cultural trust, could serve as
additional stressors that intensify the traumatic experience. As such, future studies would benefit
from continued examination of how various aspects of culture and diversity, and access to
resources affects the experience of having chronic illness and subsequent trauma.
Finally, Edmondson argued that an aspect of what makes trauma secondary to medical
events unique is the consequences of avoidance since medical patients who engage in avoidance
are likely to have poorer health outcomes. The current study provides some support for this
hypothesized relationship since higher levels of clinical symptoms were significantly positively
correlated with higher levels of avoidance. However, this correlation was not as strong as with
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some of the other symptom clusters and it will be beneficial for future research to continue to
examine this relationship.
Conclusion
This is the first study to examine the prevalence of PTSD symptomology in the IBD
population, and to examine variables that could serve as effective moderators in the impact trauma relationship. We found that among IBD patients, a significant number of participants
endorsed clinically significant levels of PTSD symptoms. We also explored the strength of the
relationships between symptoms of PTSD and measures of impact. We found that reexperiencing, reactivity and negative alterations in mood were more strongly associated with
IBD related worries and concerns than body vigilance and re-experiencing, and all the trauma
symptom clusters and body vigilance were significantly correlated with UC/CD impact.
Finally, this study sought to examine remission status, remission expectations, and
posttraumatic growth as potential moderators of the relationship between the IBD impact and
body vigilance and PTSD symptomology. While the measure of posttraumatic growth did not
function as a moderator in this study, it was found that the relationship between IBD impact and
stress symptomology was effectively moderated by current remission status and patients’
expectations of their remission.
Overall, this study should raise the awareness of medical and mental health professionals
for the potential for PTSD symptom occurrence among their IBD patients. Furthermore, the
effective moderators of remission found in this study give clinical direction to engage patients in
discussions that might decrease their fears of a future flare, and increases their confidence in
maintaining or reacquiring sustained remission.
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